Brief: Royalty Pharma - Enters Revolving Credit Agreement On May 22, 2026
28/05/2026 21:20
BRIEF-Royalty Pharma - Enters Revolving Credit Agreement On May 22, 2026 May 28 (Reuters) - Royalty Pharma PLC RPRX.O:
ROYALTY PHARMA - ENTERS REVOLVING CREDIT AGREEMENT ON MAY 22, 2026 - SEC FILING
ROYALTY PHARMA - CREDIT AGREEMENT PROVIDES FOR $1.8 BILLION UNSECURED REVOLVING CREDIT FACILITY - SEC FILING
ROYALTY PHARMA - REVOLVING CREDIT FACILITY TO MATURE ON MAY 22, 2031 - SEC FILING
Further company coverage: RPRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Royalty Pharma
See all newsAnalysis: Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
Royalty Pharma falls after Novartis' cholesterol drug fails in study
Brief: Royalty Pharma Announces Update On Novartis’ Phase 3 Topline Results For Pelacarsen
Teva's immune disorder drug meets main goal in mid-stage trial (updated)